U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Pioglitazone (marketed as Actos, Actoplus Met, Duetact, and Oseni) Information
  1. Drug Safety and Availability

Pioglitazone (marketed as Actos, Actoplus Met, Duetact, and Oseni) Information

Pioglitazone (marketed as Actos, Actoplus Met, Duetact, and Oseni) Information

Pioglitazone is sold as a single-ingredient product under the brand-name Actos and is also sold in combination with metformin (Actoplus Met, Actoplus Met XR) and glimepiride (Duetact). It is used along with diet and exercise to improve control of blood sugar in adults with type 2 diabetes mellitus.

Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.

Related Information

Labeling and Regulatory History from Drugs@FDA